Emergent BioSolutions Inc. - EBS
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Oct 07, 2026 | — | S | D | 17,800.0 | 7.09 | 126,202.0 | 111,921.0 | View | |
| Oct 05, 2026 | SVP, Products Business | S | D | 3,000.0 | 6.53 | 19,590.0 | 156,098.0 | View | |
| Jul 02, 2026 | SVP, Products Business | S | D | 3,000.0 | 8.4 | 25,200.0 | 159,098.0 | View | |
| Jun 10, 2026 | SVP, Products Business | F | D | 694.0 | 8.0 | 5,552.0 | 162,098.0 | View | |
| Jun 10, 2026 | EVP, Chief Financial Officer | F | D | 3,964.0 | 8.0 | 31,712.0 | 374,083.0 | View | |
| Jun 10, 2026 | EVP, Quality & Ethics, and CPL | F | D | 2,018.0 | 8.0 | 16,144.0 | 202,201.0 | View | |
| Jun 10, 2026 | SVP, Bioservices | F | D | 1,741.0 | 8.0 | 13,928.0 | 185,558.0 | View |